Rheumatoid lung disease with rheumatoid arthritis of hip
ICD-10 M05.15 is a billable code used to indicate a diagnosis of rheumatoid lung disease with rheumatoid arthritis of hip.
Rheumatoid lung disease is a serious complication of rheumatoid arthritis (RA), characterized by interstitial lung disease, pleural effusions, and pulmonary nodules. The hip joint, a ball-and-socket joint formed by the acetabulum of the pelvis and the head of the femur, can be affected by RA, leading to synovitis, joint erosion, and functional impairment. Patients may present with joint pain, stiffness, and decreased range of motion in the hip, alongside respiratory symptoms such as cough, dyspnea, and chest discomfort due to lung involvement. The pathophysiology involves autoimmune-mediated inflammation affecting both the synovial tissue of the hip and lung parenchyma, leading to joint destruction and pulmonary complications. Clinical management often requires a multidisciplinary approach, including rheumatologic treatment for systemic disease and orthopedic interventions for joint preservation.
Detailed imaging reports (X-rays, MRIs) showing joint erosion and functional assessments documenting range of motion and pain levels.
Patients requiring hip arthroplasty due to severe RA-related damage or those undergoing joint injections for pain management.
Documentation must reflect the severity of joint involvement and any surgical interventions performed.
Records of inflammatory markers (e.g., ESR, CRP), disease activity scores (e.g., DAS28), and treatment response.
Management of systemic symptoms alongside joint treatment, including DMARD therapy adjustments.
Monitoring for systemic manifestations and documenting any changes in lung function.
Functional assessments including mobility evaluations and rehabilitation progress notes.
Patients undergoing physical therapy for hip mobility and respiratory rehabilitation.
Assessment of assistive devices and home modifications to improve patient mobility.
Used for joint pain management in RA patients with hip involvement.
Document joint location, amount of fluid aspirated, and any therapeutic agents injected.
Orthopedic documentation must reflect the need for the procedure due to RA-related joint damage.
Key documentation includes clear evidence of rheumatoid lung disease, specific details about hip joint involvement, and any systemic symptoms. Inflammatory markers and imaging studies should also be included to support the diagnosis.
